Verzenio is a new cancer drug that has been making waves in the medical field. Developed by Eli Lilly, a leading pharmaceutical company, Verzenio is a targeted treatment for women with advanced breast cancer. But who exactly is behind the development of this life-saving medication? In this article, we will explore who makes Verzenio and the science behind it.
Verzenio is developed and manufactured by Eli Lilly and Company, a global pharmaceutical company based in Indianapolis, Indiana, USA. Eli Lilly is one of the world’s leading pharmaceutical companies, with a long history of research and development of medicines to treat a wide range of illnesses.
Who Makes Verzenio?
Verzenio is a medication used to treat certain types of breast cancer. It is manufactured by Eli Lilly and Company, a global pharmaceutical company that has been in operation since 1876. The company is based in Indianapolis, Indiana, and is one of the largest pharmaceutical companies in the world.
Components of Verzenio
Verzenio is a type of medication known as a CDK4/6 inhibitor. It works by blocking the action of two enzymes, CDK4 and CDK6, which are involved in the growth of cancer cells.
How Verzenio Is Administered
Verzenio is taken orally once a day with food. It is available in two strengths, 100 mg and 500 mg, and is taken in combination with an aromatase inhibitor. Patients may also receive a dose of Verzenio intravenously, depending on their individual needs.
Side Effects of Verzenio
Verzenio can cause side effects, including:
- Nausea
- Diarrhea
- Fatigue
- Low red blood cell count (anemia)
- Mouth sores
- Decreased appetite
- Headache
- Weight loss
Patients should speak to their doctor if they experience any of these side effects.
Conclusion
Verzenio is a medication used to treat certain types of breast cancer. It is manufactured by Eli Lilly and Company, a global pharmaceutical company based in Indianapolis, Indiana. Verzenio is a type of medication known as a CDK4/6 inhibitor, and is taken orally once a day with food. It can cause side effects, including nausea, diarrhea, fatigue, and mouth sores. Patients should speak to their doctor if they experience any of these side effects.
Frequently Asked Questions
Who Makes Verzenio?
Answer: Verzenio is made by Eli Lilly and Company. Eli Lilly and Company is a global healthcare leader that produces medicines, vaccines, and other medical products and services. It was founded in 1876 and is headquartered in Indianapolis, Indiana. Eli Lilly and Company is committed to creating medicines that make life better for people around the world.
What is Verzenio?
Answer: Verzenio is a prescription medicine used to treat a type of breast cancer called hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. It is used in combination with an aromatase inhibitor as the first hormonal-based therapy for this type of breast cancer or used alone after failure of prior endocrine therapy.
Why is Verzenio Prescribed?
Answer: Verzenio is prescribed to help slow down the growth of cancer cells in patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. It is used in combination with an aromatase inhibitor as the first hormonal-based therapy for this type of breast cancer or used alone after failure of prior endocrine therapy.
What are the Side Effects of Verzenio?
Answer: Common side effects of Verzenio include diarrhea, nausea, fatigue, vomiting, decreased appetite, stomatitis, abdominal pain, and constipation. Other side effects include increased blood cholesterol levels, elevated liver enzymes, decreased white blood cell count, and increased risk of infection.
How Does Verzenio Work?
Answer: Verzenio works by blocking the proteins that help cancer cells grow and survive. Specifically, it works by blocking a protein called cyclin-dependent kinase 4/6 (CDK4/6). By blocking CDK4/6, Verzenio helps stop the growth of cancer cells and can help slow down the growth of cancer.
What is the Cost of Verzenio?
Answer: The cost of Verzenio depends on the patient’s insurance coverage and the pharmacy they use. Generally, it will cost between $700 and $1,000 per month. Some insurance plans may cover all or some of the cost of Verzenio. Patients should check with their insurance provider to find out what coverage is available for Verzenio.
Verzenio is a prescription medication that is used to treat certain types of breast cancer. Developed by Eli Lilly and Company, Verzenio is a targeted therapy that can help reduce the risk of cancer recurrence and slow its growth. As a professional writer, I can confidently say that Verzenio is a safe and effective medication that can help people with breast cancer to live longer, healthier lives. If you or someone you love is facing breast cancer, talk to your doctor about the potential benefits of Verzenio.